$ (Millions) | $ (Millions) | $ (Millions) | £ (Millions) | £ (Millions) | |
30-Apr-23 | 30-Apr-22 | 30-Apr-21 | 30-Apr-20 | 30-Apr-19 | |
Continuing Operations | |||||
Revenue | 8,698.20 | 7,234.70 | 5,901.60 | 5,053.60 | 4,499.60 |
EBITDA | 4,411.80 | 3,609.40 | 3,036.80 | 2,375.80 | 2,106.60 |
Depreciation & Amortisation | (1,889.80) | (1,661.60) | (1,538.80) | (1,152.20) | (893.70) |
Operating Profit/(Loss) | 2,522.00 | 1,947.80 | 1,498.00 | 1,223.60 | 1,212.90 |
Interest Payable | (368.80) | (279.80) | (262.90) | (240.80) | (153.50) |
Interest Receivable/Investment Income | 2.60 | 0.10 | n/a | n/a | 0.10 |
Group Profit after Interest | 2,155.80 | 1,668.10 | 1,235.10 | 982.80 | 1,059.50 |
Share of Assoc Cos/JV Profits | n/a | n/a | n/a | n/a | n/a |
Profit Before Tax | 2,155.80 | 1,668.10 | 1,235.10 | 982.80 | 1,059.50 |
Tax | (538.10) | (417.00) | (315.00) | (243.10) | (262.60) |
Profit After Tax | 1,617.70 | 1,251.10 | 920.10 | 739.70 | 796.90 |
Discontinued Operations | |||||
Profit After Tax | n/a | n/a | n/a | n/a | n/a |
PROFIT FOR THE PERIOD | 1,617.70 | 1,251.10 | 920.10 | 739.70 | 796.90 |
Attributable to: | |||||
Equity Shareholders' Earnings | 1,617.70 | 1,251.10 | 920.10 | 739.70 | 796.90 |
Minority interests | n/a | n/a | n/a | n/a | n/a |
Equity Dividends | cn/a | cn/a | cn/a | cn/a | cn/a |
Retained Profit/(Loss) for the Financial Year | cn/a | cn/a | cn/a | cn/a | cn/a |
Per Share Record - Unadjusted | 30-Apr-23 | 30-Apr-22 | 30-Apr-21 | 30-Apr-20 | 30-Apr-19 |
Continuing EPS | |||||
Earnings per Share - Basic | 368.40¢ | 280.90¢ | 205.40¢ | 162.10p | 166.10p |
Earnings per Share - Diluted | 366.10¢ | 279.70¢ | 204.80¢ | 161.50p | 165.40p |
Continuing and Discontinued EPS | |||||
Earnings per Share - Basic | 368.40¢ | 280.90¢ | 205.40¢ | 162.10p | 166.10p |
Earnings per Share - Diluted | 366.10¢ | 279.70¢ | 204.80¢ | 161.50p | 165.40p |
Dividend per Share | 85.00¢ | 80.00¢ | 58.00¢ | 40.65p | 40.00p |
Key Financals | 30-Apr-23 | 30-Apr-22 | 30-Apr-21 | 30-Apr-20 | 30-Apr-19 |
Shares in Issue (millions) | |||||
Shares in Issue - Year End | 451.35 | 451.35 | 443.65 | 454.19 | 499.23 |
Weighted Average | 439.10 | 445.30 | 447.90 | 456.40 | 479.70 |
Diluted | 441.90 | 447.20 | 449.30 | 458.00 | 481.70 |
Performance Ratios | |||||
Continuing Operations | |||||
Operating Margin | 28.99% | 26.92% | 25.38% | 24.21% | 26.96% |
Tax Rate | 24.96% | 25.00% | 25.50% | 24.74% | 24.79% |
Return on Capital Employed | 18.44% | 17.40% | 0.16% | 14.88% | 19.38% |
Continuing Operations & Discontinued Operations | |||||
Return on Equity (ROE) | 20.02% | 18.41% | 0.15% | 17.26% | 20.39% |
Financial Status | |||||
Continuing Operations | |||||
Interest Cover | 6.85 | 6.96 | 5.70 | 5.08 | 7.90 |
Revenue per Share | 1,980.92¢ | 1,624.68¢ | 13.30¢ | 1,107.27p | 938.00p |
Pre-Tax Profit per Share | 490.96¢ | 374.60¢ | 2.78¢ | 215.34p | 220.87p |
Market Data | |||||
Continuing Operations | |||||
Earnings per Share Growth - Basic | 31% | 37% | -1% | -2% | -15% |
Earnings per Share Growth - Adjusted | 26% | 40% | -2% | 0% | 37% |
Earnings per Share Growth - Diluted | 31% | 37% | -1% | -2% | -15% |
PE Ratio - Adjusted | 15.0 | 17.4 | 27.1 | 12.4 | 12.2 |
PEG - Adjusted | 0.6 | 0.4 | n/a | n/a | 0.3 |
Dividend Cover | 4.57 | 3.84 | 3.78 | 4.31 | 4.35 |
Continuing Operations & Discontinued Operations | |||||
Earnings per Share Growth - Basic | 31% | 13,448% | -99% | -2% | -15% |
Earnings per Share Growth - Adjusted | 26% | 13,786% | -99% | 0% | 37% |
Earnings per Share Growth - Diluted | 31% | 13,430% | -99% | -2% | -15% |
PE Ratio - Adjusted | 15.0 | 17.4 | 2,682.0 | 12.4 | 12.2 |
PEG - Adjusted | 0.6 | 0.0 | n/a | n/a | 0.3 |
Dividend Cover | 4.57 | 3.84 | 0.04 | 4.31 | 4.35 |
Market Capitalisation £ (Millions) | 20,658.51 | 18,862.12 | 20,634.39 | 9,878.74 | 10,593.57 |
Dividend per Share | 85.00¢ | 80.00¢ | 58.00¢ | 40.65p | 40.00p |
Dividend Yield | 1.5% | 1.5% | 1.0% | 1.9% | 1.9% |
Dividend per Share Growth | 6.25% | 37.93% | 42.68% | 1.63% | 21.21% |
* GAAP
a. Includes discontinued activities
b. Includes preference dividends
c. Not disclosed under IFRS
You are here: research